ICPAX | VENAX | ICPAX / VENAX | |
Total Expense Ratio | 1.50 | 0.09 | 1,667% |
Annual Report Gross Expense Ratio | 1.60 | 0.09 | 1,778% |
Fund Existence | 26 years | 21 years | - |
Gain YTD | 9.627 | 0.921 | 1,045% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133M | 8.11B | 2% |
Annual Yield % from dividends | 0.87 | 3.27 | 27% |
Returns for 1 year | 15.30 | -4.70 | -326% |
Returns for 3 years | 45.09 | 21.52 | 209% |
Returns for 5 years | 169.99 | 146.88 | 116% |
Returns for 10 years | 27.57 | 17.86 | 154% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BGSRX | 72.01 | 0.92 | +1.29% |
BlackRock Technology Opportunities R | |||
DWOAX | 19.82 | 0.24 | +1.23% |
BNY Mellon Research Growth A | |||
SSEAX | 13.01 | 0.06 | +0.46% |
SEI Screened World Equity Ex-US A (SIIT) | |||
ARAFX | 11.80 | 0.02 | +0.17% |
Aristotle International Eq A | |||
VLSCX | 16.53 | N/A | N/A |
Virtus KAR Long/Short Equity C |